Skip to main content
Premium Trial:

Request an Annual Quote

Paired Ends: William Sullivan, Mike McMullen, Frederick Eibel

Premium

Agilent Technologies said that CEO William Sullivan will step down from that role on March 18, 2015, and serve as an advisor to the firm through its fiscal year ending Oct. 31, 2015. Sullivan will be succeeded by Mike McMullen, currently Agilent SVP and president of the company's Chemical Analysis Group. McMullen also was immediately named president and COO of the company in the first step of the transition. He joined Agilent's predecessor company Hewlett-Packard in 1984 as a financial analyst in its Analytical Products Group, and has since held various senior management positions as Agilent.


RainDance Technologies has named Frederick Eibel as senior vice president of strategic marketing. He most recently served as head of genetic analysis commercial operations at Agena Bioscience, which was previously the genetic analysis division of Sequenom. Prior to his time at Sequenom, he held similar leadership positions at Gen-Probe, Life Technologies, and Roche Diagnostics. He also serves on the board of MolecularMD.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.